ErbB receptor signaling in astrocytes: A mediator of neuron-glia communication in the mature central nervous system

Neurochemistry International

Volumn 57, Issue 4, 2010, Pages 344-358

  Sharif, Ariane ^a,b   Prevot, Vincent ^a,b  

^a JEAN PIERRE AUBERT RESEARCH CENTER   (France)

^b UNIV LILLE   (France)

Author keywords

Astrocytes; EGF; ErbB1; Gliotransmitter; Growth factors; Neuron glia communication; Transactivation

Indexed keywords

ADRENERGIC RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; GLUTAMATE RECEPTOR; OPIATE RECEPTOR; SEROTONIN RECEPTOR;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; CELL INTERACTION; DOPAMINERGIC NERVE CELL; HUMAN; HYPOTHALAMUS; NERVE CELL EXCITABILITY; NEUROMODULATION; NEUROTRANSMITTER RELEASE; NEUROTROPISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TRANSACTIVATION;

ANIMALS; ASTROCYTES; CELL COMMUNICATION; CENTRAL NERVOUS SYSTEM; GENES, ERBB; GLUTAMIC ACID; HUMANS; HYPOTHALAMUS; NERVOUS SYSTEM DISEASES; NEUROGLIA; NEURONS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REPRODUCTION; SIGNAL TRANSDUCTION;

EID: 77956229860     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.05.012     Document Type: Article

References (197)

1. Alexi T., Hefti F. Trophic actions of transforming growth factor alpha on mesencephalic dopaminergic neurons developing in culture. Neuroscience 1993, 55:903-918.
2. Apostolakis E.M., Garai J., Lohmann J.E., Clark J.H., O'Malley B.W. Epidermal growth factor activates reproductive behavior independent of ovarian steroids in female rodents. Mol. Endocrinol. 2000, 14:1086-1098.
3. Araque A., Carmignoto G., Haydon P.G. Dynamic signaling between astrocytes and neurons. Annu. Rev. Physiol. 2001, 63:795-813.
4. Araque A., Li N., Doyle R.T., Haydon P.G. SNARE protein-dependent glutamate release from astrocytes. J. Neurosci. 2000, 20:666-673.
5. Araujo D.M., Cotman C.W. Basic FGF in astroglial, microglial, and neuronal cultures: characterization of binding sites and modulation of release by lymphokines and trophic factors. J. Neurosci. 1992, 12:1668-1678.
6. Aronica E., Gorter J.A., Ijlst-Keizers H., Rozemuller A.J., Yankaya B., Leenstra S., Troost D. Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins. Eur. J. Neurosci. 2003, 17:2106-2118.
7. Bains J.S., Oliet S.H. Glia: they make your memories stick!. Trends Neurosci. 2007, 30:417-424.
8. Baroncini M., Allet C., Leroy D., Beauvillain J.C., Francke J.P., Prevot V. Morphological evidence for direct interaction between gonadotrophin-releasing hormone neurones and astroglial cells in the human hypothalamus. J. Neuroendocrinol. 2007, 19:691-702.
9. Bekar L.K., He W., Nedergaard M. Locus coeruleus alpha-adrenergic-mediated activation of cortical astrocytes in vivo. Cereb. Cortex 2008, 18:2789-2795.
10. Belcheva M.M., Tan Y., Heaton V.M., Clark A.L., Coscia C.J. Mu opioid transactivation and down-regulation of the epidermal growth factor receptor in astrocytes: implications for mitogen-activated protein kinase signaling. Mol. Pharmacol. 2003, 64:1391-1401.
11. Benzel I., Bansal A., Browning B.L., Galwey N.W., Maycox P.R., McGinnis R., Smart D., St Clair D., Yates P., Purvis I. Interactions among genes in the ErbB-Neuregulin signalling network are associated with increased susceptibility to schizophrenia. Behav. Brain Funct. 2007, 3:31.
12. Bouret S., De Seranno S., Beauvillain J.C., Prevot V. Transforming growth factor beta1 may directly influence gonadotropin-releasing hormone gene expression in the rat hypothalamus. Endocrinology 2004, 145:1794-1801.
13. Bouvier-Labit C., Chinot O., Ochi C., Gambarelli D., Dufour H., Figarella-Branger D. Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas. Neuropathol. Appl. Neurobiol. 1998, 24:381-388.
14. Burrows R.C., Levitt P., Shors T.J. Postnatal decrease in transforming growth factor alpha is associated with enlarged ventricles, deficient amygdaloid vasculature and performance deficits. Neuroscience 2000, 96:825-836.
15. Buxbaum J.D., Georgieva L., Young J.J., Plescia C., Kajiwara Y., Jiang Y., Moskvina V., Norton N., Peirce T., Williams H., Craddock N.J., Carroll L., Corfas G., Davis K.L., Owen M.J., Harroch S., Sakurai T., O'Donovan M.C. Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene. Mol. Psychiatry 2008, 13:162-172.
16. Casper D., Mytilineou C., Blum M. EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture. J. Neurosci. Res. 1991, 30:372-381.
17. Chaudhury A.R., Gerecke K.M., Wyss J.M., Morgan D.G., Gordon M.N., Carroll S.L. Neuregulin-1 and erbB4 immunoreactivity is associated with neuritic plaques in Alzheimer disease brain and in a transgenic model of Alzheimer disease. J. Neuropathol. Exp. Neurol. 2003, 62:42-54.
18. Chen S., Velardez M.O., Warot X., Yu Z.X., Miller S.J., Cros D., Corfas G. Neuregulin 1-erbB signaling is necessary for normal myelination and sensory function. J. Neurosci. 2006, 26:3079-3086.
19. Chernausek S.D. Insulin-like growth factor-I (IGF-I) production by astroglial cells: regulation and importance for epidermal growth factor-induced cell replication. J. Neurosci. Res. 1993, 34:189-197.
20. Citri A., Yarden Y. EGF-ERBB signalling: towards the systems level. Nat. Rev. Mol. Cell Biol. 2006, 7:505-516.
21. Clasadonte, J.M., Poulain, P., Hanchate, N.K., Mazur, D., Corfas, G., Ojeda, S.R., Prevot, V., 2009. PGE2 directly excites GnRH neurons through activation of EP2 receptors: a possible role for astrocytes. Soc. Neurosci. [186.4/DD37] (Ref. type: abstract).
22. Corfas G., Roy K., Buxbaum J.D. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat. Neurosci. 2004, 7:575-580.
23. Corfas G., Velardez M.O., Ko C.P., Ratner N., Peles E. Mechanisms and roles of axon-Schwann cell interactions. J. Neurosci. 2004, 24:9250-9260.
24. Cotter D.R., Pariante C.M., Everall I.P. Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res. Bull. 2001, 55:585-595.
25. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 2001, 65:1-105.
26. De Saint Jan D., Westbrook G.L. Detecting activity in olfactory bulb glomeruli with astrocyte recording. J. Neurosci. 2005, 25:2917-2924.
27. Diamond J.S., Bergles D.E., Jahr C.E. Glutamate release monitored with astrocyte transporter currents during LTP. Neuron 1998, 21:425-433.
28. Du T., Li B., Liu S., Zang P., Prevot V., Hertz L., Peng L. ERK phosphorylation in intact, adult brain by alpha(2)-adrenergic transactivation of EGF receptors. Neurochem. Int. 2009, 55:593-600.
29. Dufour C., Cadusseau J., Varlet P., Surena A.L., de Faria G.P., Dias-Morais A., Auger N., Leonard N., Daudigeos E., Dantas-Barbosa C., Grill J., Lazar V., Dessen P., Vassal G., Prevot V., Sharif A., Chneiweiss H., Junier M.P. Astrocytes reverted to a neural progenitor-like state with transforming growth factor alpha are sensitized to cancerous transformation. Stem Cells 2009, 27:2373-2382.
30. Duhem-Tonnelle V., Bièche I., Vacher S., Loyens A., Maurage C.A., Collier F., Baroncini M., Blond S., Prevot V., Sharif A. Differential Distribution of erbB Receptors in Human Glioblastoma Multiforme: Expression of erbB3 in CD133-Positive Putative Cancer Stem Cells. J. Neuropathol. Exp. Neurol. 2010, 69:606-622.
31. Dziedzic B., Prevot V., Lomniczi A., Jung H., Cornea A., Ojeda S.R. Neuron-to-glia signaling mediated by excitatory amino acid receptors regulates ErbB receptor function in astroglial cells of the neuroendocrine brain. J. Neurosci. 2003, 23:915-926.
32. Egea J., Espinet C., Comella J.X. Calcium influx activates extracellular-regulated kinase/mitogen-activated protein kinase pathway through a calmodulin-sensitive mechanism in PC12 cells. J. Biol. Chem. 1999, 274:75-85.
33. Engele J. Changing responsiveness of developing midbrain dopaminergic neurons for extracellular growth factors. J. Neurosci. Res. 1998, 51:508-516.
34. Engele J., Schilling K. Growth factor-induced c-fos expression defines distinct subsets of midbrain dopaminergic neurons. Neuroscience 1996, 73:397-406.
35. Farkas L.M., Krieglstein K. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) regulates survival of midbrain dopaminergic neurons. J. Neural Transm. 2002, 109:267-277.
36. Feldkamp M.M., Lala P., Lau N., Roncari L., Guha A. Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens. Neurosurgery 1999, 45:1442-1453.
37. Gabriel C., Ali C., Lesne S., Fernandez-Monreal M., Docagne F., Plawinski L., MacKenzie E.T., Buisson A., Vivien D. Transforming growth factor alpha-induced expression of type 1 plasminogen activator inhibitor in astrocytes rescues neurons from excitotoxicity. Faseb J. 2003, 17:277-279.
38. Galbiati M., Martini L., Melcangi R.C. Oestrogens, via transforming growth factor alpha, modulate basic fibroblast growth factor synthesis in hypothalamic astrocytes: in vitro observations. J. Neuroendocrinol. 2002, 14:829-835.
39. Garcia-Segura L.M., McCarthy M.M. Minireview: role of glia in neuroendocrine function. Endocrinology 2004, 145:1082-1086.
40. Ge W.P., Duan S. Persistent enhancement of neuron-glia signaling mediated by increased extracellular K+ accompanying long-term synaptic potentiation. J. Neurophysiol. 2007, 97:2564-2569.
41. Gegelashvili G., Dehnes Y., Danbolt N.C., Schousboe A. The high-affinity glutamate transporters GLT1, GLAST, and EAAT4 are regulated via different signalling mechanisms. Neurochem. Int. 2000, 37:163-170.
42. Gerecke K.M., Wyss J.M., Karavanova I., Buonanno A., Carroll S.L. ErbB transmembrane tyrosine kinase receptors are differentially expressed throughout the adult rat central nervous system. J. Comp. Neurol. 2001, 433:86-100.
43. Ghashghaei H.T., Weimer J.M., Schmid R.S., Yokota Y., McCarthy K.D., Popko B., Anton E.S. Reinduction of ErbB2 in astrocytes promotes radial glial progenitor identity in adult cerebral cortex. Genes Dev. 2007, 21:3258-3271.
44. Gordon G.R., Baimoukhametova D.V., Hewitt S.A., Rajapaksha W.R., Fisher T.E., Bains J.S. Norepinephrine triggers release of glial ATP to increase postsynaptic efficacy. Nat. Neurosci. 2005, 8:1078-1086.
45. Gordon G.R., Iremonger K.J., Kantevari S., Ellis-Davies G.C., MacVicar B.A., Bains J.S. Astrocyte-mediated distributed plasticity at hypothalamic glutamate synapses. Neuron 2009, 64:391-403.
46. Grove J., Gomez J., Kentroti S., Vernadakis A. Plasticity of astrocytes derived from aged mouse cerebral hemispheres: changes with cell passage and immortalization. Brain Res. Bull. 1996, 39:211-217.
47. Gschwind A., Zwick E., Prenzel N., Leserer M., Ullrich A. Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission. Oncogene 2001, 20:1594-1600.
48. Hahn C.G., Wang H.Y., Cho D.S., Talbot K., Gur R.E., Berrettini W.H., Bakshi K., Kamins J., Borgmann-Winter K.E., Siegel S.J., Gallop R.J., Arnold S.E. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat. Med. 2006, 12:824-828.
49. Hakak Y., Walker J.R., Li C., Wong W.H., Davis K.L., Buxbaum J.D., Haroutunian V., Fienberg A.A. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:4746-4751.
50. Han V.K., Smith A., Myint W., Nygard K., Bradshaw S. Mitogenic activity of epidermal growth factor on newborn rat astroglia: interaction with insulin-like growth factors. Endocrinology 1992, 131:1134-1142.
51. Hansson E., Ronnback L. Astrocytic receptors and second messenger systems. Non-neuronal Cells of the Nervous System: Function and Dysfunction 2004, vol. 31-II:475-501. Elsevier, Amsterdam.
52. Hatton G.I. Function-related plasticity in hypothalamus. Annu. Rev. Neurosci. 1997, 20:375-397.
53. Haydon P.G., Carmignoto G. Astrocyte control of synaptic transmission and neurovascular coupling. Physiol. Rev. 2006, 86:1009-1031.
54. Hazell A.S., Pannunzio P., Rama Rao K.V., Pow D.V., Rambaldi A. Thiamine deficiency results in downregulation of the GLAST glutamate transporter in cultured astrocytes. Glia 2003, 43:175-184.
55. Herbison A.E., Neill J.D. Physiology of the gonadotropin-releasing hormone neuronal network. Knobil and Neill's Physiology of Reproduction 2006, Elsevier, pp. 1415-1482.
56. Hertz L., Chen Y., Gibbs M.E., Zang P., Peng L. Astrocytic adrenoceptors: a major drug target in neurological and psychiatric disorders?. Curr. Drug Targets CNS Neurol. Disord. 2004, 3:239-267.
57. Hertz L., Zielke H.R. Astrocytic control of glutamatergic activity: astrocytes as stars of the show. Trends Neurosci. 2004, 27:735-743.
58. Hiesiger E.M., Hayes R.L., Pierz D.M., Budzilovich G.N. Prognostic relevance of epidermal growth factor receptor (EGF-R) and c-neu/erbB2 expression in glioblastomas (GBMs). J. Neurooncol. 1993, 16:93-104.
59. Hilakivi-Clarke L.A., Arora P.K., Clarke R., Wright A., Lippman M.E., Dickson R.B. Opposing behavioural alterations in male and female transgenic TGF alpha mice: association with tumour susceptibility. Br. J. Cancer 1993, 67:1026-1030.
60. Hilakivi-Clarke L.A., Arora P.K., Sabol M.B., Clarke R., Dickson R.B., Lippman M.E. Alterations in behavior, steroid hormones and natural killer cell activity in male transgenic TGF alpha mice. Brain Res. 1992, 588:97-103.
61. Hunter S.B., Abbott K., Varma V.A., Olson J.J., Barnett D.W., James C.D. Reliability of differential PCR for the detection of EGFR and MDM2 gene amplification in DNA extracted from FFPE glioma tissue. J. Neuropathol. Exp. Neurol. 1995, 54:57-64.
62. Hynes N.E., Lane H.A. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat. Rev. Cancer 2005, 5:341-354.
63. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat. Rev. Neurosci. 2004, 5:347-360.
64. Iadecola C., Nedergaard M. Glial regulation of the cerebral microvasculature. Nat. Neurosci. 2007, 10:1369-1376.
65. Iwakura Y., Piao Y.S., Mizuno M., Takei N., Kakita A., Takahashi H., Nawa H. Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson's disease and its model: neurotrophic implication in nigrostriatal neurons. J. Neurochem. 2005, 93:974-983.
66. Jiang X., Sinnett-Smith J., Rozengurt E. Carbachol induces p70S6K1 activation through an ERK-dependent but Akt-independent pathway in human colonic epithelial cells. Biochem. Biophys. Res. Commun. 2009, 387:521-524.
67. Jones R.B., Gordus A., Krall J.A., MacBeath G. A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature 2006, 439:168-174.
68. Jourdain P., Bergersen L.H., Bhaukaurally K., Bezzi P., Santello M., Domercq M., Matute C., Tonello F., Gundersen V., Volterra A. Glutamate exocytosis from astrocytes controls synaptic strength. Nat. Neurosci. 2007, 10:331-339.
69. Jung H., Carmel P., Schwartz M.S., Witkin J.W., Bentele K.H., Westphal M., Piatt J.H., Costa M.E., Cornea A., Ma Y.J., Ojeda S.R. Some hypothalamic hamartomas contain transforming growth factor alpha, a puberty-inducing growth factor, but not luteinizing hormone-releasing hormone neurons. J. Clin. Endocrinol. Metab. 1999, 84:4695-4701.
70. Junier M.P. What role(s) for TGFalpha in the central nervous system?. Prog. Neurobiol. 2000, 62:443-473.
71. Junier M.P., Ma Y.J., Costa M.E., Hoffman G., Hill D.F., Ojeda S.R. Transforming growth factor alpha contributes to the mechanism by which hypothalamic injury induces precocious puberty. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:9743-9747.
72. Justicia C., Perez-Asensio F.J., Burguete M.C., Salom J.B., Planas A.M. Administration of transforming growth factor-alpha reduces infarct volume after transient focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 2001, 21:1097-1104.
73. Justicia C., Planas A.M. Transforming growth factor-alpha acting at the epidermal growth factor receptor reduces infarct volume after permanent middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 1999, 19:128-132.
74. Kamiguchi H., Yoshida K., Sagoh M., Sasaki H., Inaba M., Wakamoto H., Otani M., Toya S. Release of ciliary neurotrophic factor from cultured astrocytes and its modulation by cytokines. Neurochem. Res. 1995, 20:1187-1193.
75. Kamiguchi H., Yoshida K., Wakamoto H., Inaba M., Sasaki H., Otani M., Toya S. Cytokine-induced selective increase of high-molecular-weight bFGF isoforms and their subcellular kinetics in cultured rat hippocampal astrocytes. Neurochem. Res. 1996, 21:701-706.
76. Kanda Y., Watanabe Y. Nicotine-induced vascular endothelial growth factor release via the EGFR-ERK pathway in rat vascular smooth muscle cells. Life Sci. 2007, 80:1409-1414.
77. Kang J., Kang N., Lovatt D., Torres A., Zhao Z., Lin J., Nedergaard M. Connexin 43 hemichannels are permeable to ATP. J. Neurosci. 2008, 28:4702-4711.
78. Kazazoglou T., Fleischer-Lambropoulos E., Geladopoulos T., Kentroti S., Stefanis C., Vernadakis A. Differential responsiveness of late passage C-6 glial cells and advanced passages of astrocytes derived from aged mouse cerebral hemispheres to cytokines and growth factors: glutamine synthetase activity. Neurochem. Res. 1996, 21:609-614.
79. King J.C., Letourneau R.J. Luteinizing hormone-releasing hormone terminals in the median eminence of rats undergo dramatic changes after gonadectomy, as revealed by electron microscopic image analysis. Endocrinology 1994, 134:1340-1351.
80. Knusel B., Michel P.P., Schwaber J.S., Hefti F. Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II. J. Neurosci. 1990, 10:558-570.
81. Kondziella D., Brenner E., Eyjolfsson E.M., Sonnewald U. How do glial-neuronal interactions fit into current neurotransmitter hypotheses of schizophrenia?. Neurochem. Int. 2007, 50:291-301.
82. Kong E.K., Peng L., Chen Y., Yu A.C., Hertz L. Up-regulation of 5-HT2B receptor density and receptor-mediated glycogenolysis in mouse astrocytes by long-term fluoxetine administration. Neurochem. Res. 2002, 27:113-120.
83. Kornblum H.I., Hussain R., Wiesen J., Miettinen P., Zurcher S.D., Chow K., Derynck R., Werb Z. Abnormal astrocyte development and neuronal death in mice lacking the epidermal growth factor receptor. J. Neurosci. Res. 1998, 53:697-717.
84. Koshibu K., Ahrens E.T., Levitt P. Postpubertal sex differentiation of forebrain structures and functions depend on transforming growth factor-alpha. J. Neurosci. 2005, 25:3870-3880.
85. Krieg T., Cui L., Qin Q., Cohen M.V., Downey J.M. Mitochondrial ROS generation following acetylcholine-induced EGF receptor transactivation requires metalloproteinase cleavage of proHB-EGF. J. Mol. Cell Cardiol. 2004, 36:435-443.
86. Kristt D.A., Reedy E., Yarden Y. Receptor tyrosine kinase expression in astrocytic lesions: similar features in gliosis and glioma. Neurosurgery 1993, 33:106-115.
87. Kristt D.A., Yarden Y. Differences between phosphotyrosine accumulation and Neu/ErbB-2 receptor expression in astrocytic proliferative processes. Implications for glial oncogenesis. Cancer 1996, 78:1272-1283.
88. Kuhmonen J., Pokorny J., Miettinen R., Haapalinna A., Jolkkonen J., Riekkinen P., Sivenius J. Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia. Anesthesiology 1997, 87:371-377.
89. Kuhn P.E., Miller M.W. c-neu oncoprotein in developing rostral cerebral cortex: relationship to epidermal growth factor receptor. J. Comp. Neurol. 1996, 372:189-203.
90. Law A.J., Kleinman J.E., Weinberger D.R., Weickert C.S. Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum. Mol. Genet. 2007, 16:129-141.
91. Lenferink A.E., Pinkas-Kramarski R., van de Poll M.L., van Vugt M.J., Klapper L.N., Tzahar E., Waterman H., Sela M., van Zoelen E.J., Yarden Y. Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers. Embo J. 1998, 17:3385-3397.
92. Li B., Du T., Li H., Gu L., Zhang H., Huang J., Hertz L., Peng L. Signalling pathways for transactivation by dexmedetomidine of epidermal growth factor receptors in astrocytes and its paracrine effect on neurons. Br. J. Pharmacol. 2008, 154:191-203.
93. Li B., Woo R.S., Mei L., Malinow R. The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron 2007, 54:583-597.
94. Li B., Zhang S., Li M., Hertz L., Peng L. Chronic treatment of astrocytes with therapeutically relevant fluoxetine concentrations enhances cPLA2 expression secondary to 5-HT2B-induced, transactivation-mediated ERK1/2 phosphorylation. Psychopharmacology (Berl) 2009, 207:1-12.
95. Li B., Zhang S., Zhang H., Nu W., Cai L., Hertz L., Peng L. Fluoxetine-mediated 5-HT2B receptor stimulation in astrocytes causes EGF receptor transactivation and ERK phosphorylation. Psychopharmacology (Berl) 2008, 201:443-458.
96. Li L.B., Toan S.V., Zelenaia O., Watson D.J., Wolfe J.H., Rothstein J.D., Robinson M.B. Regulation of astrocytic glutamate transporter expression by Akt: evidence for a selective transcriptional effect on the GLT-1/EAAT2 subtype. J. Neurochem. 2006, 97:759-771.
97. Lindholm D., Castren E., Kiefer R., Zafra F., Thoenen H. Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J. Cell Biol. 1992, 117:395-400.
98. Liu B., Neufeld A.H. Activation of epidermal growth factor receptor signals induction of nitric oxide synthase-2 in human optic nerve head astrocytes in glaucomatous optic neuropathy. Neurobiol. Dis. 2003, 13:109-123.
99. Lomniczi A., Cornea A., Costa M.E., Ojeda S.R. Hypothalamic tumor necrosis factor-alpha converting enzyme mediates excitatory amino acid-dependent neuron-to-glia signaling in the neuroendocrine brain. J. Neurosci. 2006, 26:51-62.
100. Loret C., Sensenbrenner M., Labourdette G. Differential phenotypic expression induced in cultured rat astroblasts by acidic fibroblast growth factor, epidermal growth factor, and thrombin. J. Biol. Chem. 1989, 264:8319-8327.
101. Luscher C., Malenka R.C., Nicoll R.A. Monitoring glutamate release during LTP with glial transporter currents. Neuron 1998, 21:435-441.
102. Ma Y.J., Berg-von der Emde K., Rage F., Wetsel W.C., Ojeda S.R. Hypothalamic astrocytes respond to transforming growth factor-alpha with the secretion of neuroactive substances that stimulate the release of luteinizing hormone-releasing hormone. Endocrinology 1997, 138:19-25.
103. Ma Y.J., Hill D.F., Creswick K.E., Costa M.E., Cornea A., Lioubin M.N., Plowman G.D., Ojeda S.R. Neuregulins signaling via a glial erbB-2-erbB-4 receptor complex contribute to the neuroendocrine control of mammalian sexual development. J. Neurosci. 1999, 19:9913-9927.
104. Ma Y.J., Hill D.F., Junier M.P., Costa M.E., Felder S.E., Ojeda S.R. Expression of epidermal growth factor receptor changes in the hypothalamus during the onset of female puberty. Mol. Cell Neurosci. 1994, 5:246-262.
105. Ma Y.J., Junier M.P., Costa M.E., Ojeda S.R. Transforming growth factor-alpha gene expression in the hypothalamus is developmentally regulated and linked to sexual maturation. Neuron 1992, 9:657-670.
106. Madrigal J.L., Leza J.C., Polak P., Kalinin S., Feinstein D.L. Astrocyte-derived MCP-1 mediates neuroprotective effects of noradrenaline. J. Neurosci. 2009, 29:263-267.
107. Malarkey E.B., Parpura V. Mechanisms of glutamate release from astrocytes. Neurochem. Int. 2008, 52:142-154.
108. Martineau M., Baux G., Mothet J.P. d-serine signalling in the brain: friend and foe. Trends Neurosci. 2006, 29:481-491.
109. Martinez A.D., Saez J.C. Arachidonic acid-induced dye uncoupling in rat cortical astrocytes is mediated by arachidonic acid byproducts. Brain Res. 1999, 816:411-423.
110. McLennan G.P., Kiss A., Miyatake M., Belcheva M.M., Chambers K.T., Pozek J.J., Mohabbat Y., Moyer R.A., Bohn L.M., Coscia C.J. Kappa opioids promote the proliferation of astrocytes via Gbetagamma and beta-arrestin 2-dependent MAPK-mediated pathways. J. Neurochem. 2008, 107:1753-1765.
111. Melcangi R.C., Galbiati M., Messi E., Piva F., Martini L., Motta M. Type 1 astrocytes influence luteinizing hormone-releasing hormone release from the hypothalamic cell line GT1-1: is transforming growth factor-beta the principle involved?. Endocrinology 1995, 136:679-686.
112. Miller M.W., Pitts F.A. Neurotrophin receptors in the somatosensory cortex of the mature rat: co-localization of p75, trk, isoforms and c-neu. Brain Res. 2000, 852:355-366.
113. Miller S., Romano C., Cotman C.W. Growth factor upregulation of a phosphoinositide-coupled metabotropic glutamate receptor in cortical astrocytes. J. Neurosci. 1995, 15:6103-6109.
114. Minoshima T., Nakanishi S. Structural organization of the mouse metabotropic glutamate receptor subtype 3 gene and its regulation by growth factors in cultured cortical astrocytes. J. Biochem. 1999, 126:889-896.
115. Miyatake M., Rubinstein T.J., McLennan G.P., Belcheva M.M., Coscia C.J. Inhibition of EGF-induced ERK/MAP kinase-mediated astrocyte proliferation by mu opioids: integration of G protein and beta-arrestin 2-dependent pathways. J. Neurochem. 2009, 110:662-674.
116. Moffett J., Kratz E., Myers J., Stachowiak E.K., Florkiewicz R.Z., Stachowiak M.K. Transcriptional regulation of fibroblast growth factor-2 expression in human astrocytes: implications for cell plasticity. Mol. Biol. Cell 1998, 9:2269-2285.
117. Montero J.C., Yuste L., Diaz-Rodriguez E., Esparis-Ogando A., Pandiella A. Differential shedding of transmembrane neuregulin isoforms by the tumor necrosis factor-alpha-converting enzyme. Mol. Cell Neurosci. 2000, 16:631-648.
118. Montiel M., Quesada J., Jimenez E. Activation of calcium-dependent kinases and epidermal growth factor receptor regulate muscarinic acetylcholine receptor-mediated MAPK/ERK activation in thyroid epithelial cells. Cell Signal. 2007, 19:2138-2146.
119. Morita M., Higuchi C., Moto T., Kozuka N., Susuki J., Itofusa R., Yamashita J., Kudo Y. Dual regulation of calcium oscillation in astrocytes by growth factors and pro-inflammatory cytokines via the mitogen-activated protein kinase cascade. J. Neurosci. 2003, 23:10944-10952.
120. Morita M., Kozuka N., Itofusa R., Yukawa M., Kudo Y. Autocrine activation of EGF receptor promotes oscillation of glutamate-induced calcium increase in astrocytes cultured in rat cerebral cortex. J. Neurochem. 2005, 95:871-879.
121. Morita M., Saruta C., Kozuka N., Okubo Y., Itakura M., Takahashi M., Kudo Y. Dual regulation of astrocyte gap junction hemichannels by growth factors and a pro-inflammatory cytokine via the mitogen-activated protein kinase cascade. Glia 2007, 55:508-515.
122. Morrison P., Saltiel A.R., Rosner M.R. Role of mitogen-activated protein kinase kinase in regulation of the epidermal growth factor receptor by protein kinase C. J. Biol. Chem. 1996, 271:12891-12896.
123. Morrison P., Takishima K., Rosner M.R. Role of threonine residues in regulation of the epidermal growth factor receptor by protein kinase C and mitogen-activated protein kinase. J. Biol. Chem. 1993, 268:15536-15543.
124. Morrison R.S., Kornblum H.I., Leslie F.M., Bradshaw R.A. Trophic stimulation of cultured neurons from neonatal rat brain by epidermal growth factor. Science 1987, 238:72-75.
125. Nakayama H., Numakawa T., Ikeuchi T. Nicotine-induced phosphorylation of Akt through epidermal growth factor receptor and Src in PC12h cells. J. Neurochem. 2002, 83:1372-1379.
126. Nieto-Sampedro M., Gomez-Pinilla F., Knauer D.J., Broderick J.T. Epidermal growth factor receptor immunoreactivity in rat brain astrocytes. Response to injury. Neurosci. Lett. 1988, 91:276-282.
127. Oberheim N.A., Wang X., Goldman S., Nedergaard M. Astrocytic complexity distinguishes the human brain. Trends Neurosci. 2006, 29:547-553.
128. Ojeda S.R., Lomniczi A., Mastronardi C., Heger S., Roth C., Parent A.S., Matagne V., Mungenast A.E. Minireview: the neuroendocrine regulation of puberty: is the time ripe for a systems biology approach?. Endocrinology 2006, 147:1166-1174.
129. Ojeda S.R., Ma Y.J., Lee B.J., Prevot V. Glia-to-neuron signaling and the neuroendocrine control of female puberty. Recent Prog. Horm. Res. 2000, 55:197-223. discussion 223-194.
130. Ojeda S.R., Prevot V., Heger S., Lomniczi A., Dziedzic B., Mungenast A. Glia-to-neuron signaling and the neuroendocrine control of female puberty. Ann. Med. 2003, 35:244-255.
131. Ojeda S.R., Terasawa E., Pfaff D., Arnold A., Etgen A., Fahrbach S., Moss R., Rubin R. Neuroendocrine Regulation of Puberty 2002, Elsevier, New York, pp. 589-659.
132. Olayioye M.A., Neve R.M., Lane H.A., Hynes N.E. The ErbB signaling network: receptor heterodimerization in development and cancer. Embo J. 2000, 19:3159-3167.
133. Panatier A., Theodosis D.T., Mothet J.P., Touquet B., Pollegioni L., Poulain D.A., Oliet S.H. Glia-derived d-serine controls NMDA receptor activity and synaptic memory. Cell 2006, 125:775-784.
134. Pandiella A., Massague J. Multiple signals activate cleavage of the membrane transforming growth factor-alpha precursor. J. Biol. Chem. 1991, 266:5769-5773.
135. Park T.H., Mytilineou C. Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF. Brain Res. 1992, 599:83-97.
136. Parpura V., Haydon P.G. Physiological astrocytic calcium levels stimulate glutamate release to modulate adjacent neurons. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:8629-8634.
137. Pascual O., Casper K.B., Kubera C., Zhang J., Revilla-Sanchez R., Sul J.Y., Takano H., Moss S.J., McCarthy K., Haydon P.G. Astrocytic purinergic signaling coordinates synaptic networks. Science 2005, 310:113-116.
138. Peavy R.D., Chang M.S., Sanders-Bush E., Conn P.J. Metabotropic glutamate receptor 5-induced phosphorylation of extracellular signal-regulated kinase in astrocytes depends on transactivation of the epidermal growth factor receptor. J. Neurosci. 2001, 21:9619-9628.
139. Peng L. Transactivation in astrocytes as a novel mechanism of neuroprotection. Non-neuronal Cells of the Nervous System: Function and Dysfunction 2004, vol. 31-II:503-518. Elsevier, Amsterdam.
140. Peng L., Yu A.C., Fung K.Y., Prevot V., Hertz L. Alpha-adrenergic stimulation of ERK phosphorylation in astrocytes is alpha(2)-specific and may be mediated by transactivation. Brain Res. 2003, 978:65-71.
141. Porter J.T., McCarthy K.D. Astrocytic neurotransmitter receptors in situ and in vivo. Prog. Neurobiol. 1997, 51:439-455.
142. Prenzel N., Zwick E., Daub H., Leserer M., Abraham R., Wallasch C., Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 1999, 402:884-888.
143. Prevot V. Glial-neuronal-endothelial interactions are involved in the control of GnRH secretion. J. Neuroendocrinol. 2002, 14:247-255.
144. Prevot V., Cornea A., Mungenast A., Smiley G., Ojeda S.R. Activation of erbB-1 signaling in tanycytes of the median eminence stimulates transforming growth factor beta1 release via prostaglandin E2 production and induces cell plasticity. J. Neurosci. 2003, 23:10622-10632.
145. Prevot V., Dehouck B., Poulain P., Beauvillain J.C., Buee-Scherrer V., Bouret S. Neuronal-glial-endothelial interactions and cell plasticity in the postnatal hypothalamus: implications for the neuroendocrine control of reproduction. Psychoneuroendocrinology 2007, 32(Suppl 1):S46-S51.
146. Prevot V., Lomniczi A., Corfas G., Ojeda S.R. erbB-1 and erbB-4 receptors act in concert to facilitate female sexual development and mature reproductive function. Endocrinology 2005, 146:1465-1472.
147. Prevot V., Rio C., Cho G.J., Lomniczi A., Heger S., Neville C.M., Rosenthal N.A., Ojeda S.R., Corfas G. Normal female sexual development requires neuregulin-erbB receptor signaling in hypothalamic astrocytes. J. Neurosci. 2003, 23:230-239.
148. Regan M.R., Huang Y.H., Kim Y.S., Dykes-Hoberg M.I., Jin L., Watkins A.M., Bergles D.E., Rothstein J.D. Variations in promoter activity reveal a differential expression and physiology of glutamate transporters by glia in the developing and mature CNS. J. Neurosci. 2007, 27:6607-6619.
149. Ridet J.L., Malhotra S.K., Privat A., Gage F.H. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 1997, 20:570-577.
150. Riese D.J., Stern D.F. Specificity within the EGF family/ErbB receptor family signaling network. Bioessays 1998, 20:41-48.
151. Riese D.J., Kim E.D., Elenius K., Buckley S., Klagsbrun M., Plowman G.D., Stern D.F. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4. J. Biol. Chem. 1996, 271:20047-20052.
152. Rodriguez J.J., Olabarria M., Chvatal A., Verkhratsky A. Astroglia in dementia and Alzheimer's disease. Cell Death Differ. 2009, 16:378-385.
153. Rosen L.B., Greenberg M.E. Stimulation of growth factor receptor signal transduction by activation of voltage-sensitive calcium channels. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:1113-1118.
154. Roy K., Murtie J.C., El-Khodor B.F., Edgar N., Sardi S.P., Hooks B.M., Benoit-Marand M., Chen C., Moore H., O'Donnell P., Brunner D., Corfas G. Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:8131-8136.
155. Sanden N., Thorlin T., Blomstrand F., Persson P.A., Hansson E. 5-Hydroxytryptamine2B receptors stimulate Ca2+ increases in cultured astrocytes from three different brain regions. Neurochem. Int. 2000, 36:427-434.
156. Sanderson M.P., Dempsey P.J., Dunbar A.J. Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors. Growth Factors 2006, 24:121-136.
157. Sardi S.P., Murtie J., Koirala S., Patten B.A., Corfas G. Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain. Cell 2006, 127:185-197.
158. Sargeant T.J., Miller J.H., Day D.J. Opioidergic regulation of astroglial/neuronal proliferation: where are we now?. J. Neurochem. 2008, 107:883-897.
159. Schmid R.S., McGrath B., Berechid B.E., Boyles B., Marchionni M., Sestan N., Anton E.S. Neuregulin 1-erbB2 signaling is required for the establishment of radial glia and their transformation into astrocytes in cerebral cortex. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:4251-4256.
160. Seifert G., Schilling K., Steinhauser C. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat. Rev. Neurosci. 2006, 7:194-206.
161. Seigneur J., Kroeger D., Nita D.A., Amzica F. Cholinergic action on cortical glial cells in vivo. Cereb. Cortex 2006, 16:655-668.
162. Sharif A., Duhem-Tonnelle V., Allet C., Baroncini M., Loyens A., Kerr-Conte J., Collier F., Blond S., Ojeda S.R., Junier M.P., Prevot V. Differential erbB signaling in astrocytes from the cerebral cortex and the hypothalamus of the human brain. Glia 2009, 57:362-379.
163. Sharif A., Legendre P., Prevot V., Allet C., Romao L., Studler J.M., Chneiweiss H., Junier M.P. Transforming growth factor alpha promotes sequential conversion of mature astrocytes into neural progenitors and stem cells. Oncogene 2007, 26:2695-2706.
164. Sharif A., Prevot V., Renault-Mihara F., Allet C., Studler J.M., Canton B., Chneiweiss H., Junier M.P. Transforming growth factor alpha acts as a gliatrophin for mouse and human astrocytes. Oncogene 2006, 25:4076-4085.
165. Sibilia M., Steinbach J.P., Stingl L., Aguzzi A., Wagner E.F. A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor. Embo J. 1998, 17:719-731.
166. Snodgrass-Belt P., Gilbert J.L., Davis F.C. Central administration of transforming growth factor-alpha and neuregulin-1 suppress active behaviors and cause weight loss in hamsters. Brain Res. 2005, 1038:171-182.
167. Straub S.V., Nelson M.T. Astrocytic calcium signaling: the information currency coupling neuronal activity to the cerebral microcirculation. Trends Cardiovasc. Med. 2007, 17:183-190.
168. Suzuki K., Ikegaya Y., Matsuura S., Kanai Y., Endou H., Matsuki N. Transient upregulation of the glial glutamate transporter GLAST in response to fibroblast growth factor, insulin-like growth factor and epidermal growth factor in cultured astrocytes. J. Cell Sci. 2001, 114:3717-3725.
169. Theodosis D.T., Trailin A., Poulain D.A. Remodeling of astrocytes, a prerequisite for synapse turnover in the adult brain? Insights from the oxytocin system of the hypothalamus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 290:R1175-R1182.
170. Tkachev D., Mimmack M.L., Ryan M.M., Wayland M., Freeman T., Jones P.B., Starkey M., Webster M.J., Yolken R.H., Bahn S. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003, 362:798-805.
171. Tokita Y., Keino H., Matsui F., Aono S., Ishiguro H., Higashiyama S., Oohira A. Regulation of neuregulin expression in the injured rat brain and cultured astrocytes. J. Neurosci. 2001, 21:1257-1264.
172. Torp S.H., Gulati S., Johannessen E., Dalen A. Coexpression of c-erbB 1-4 receptor proteins in human glioblastomas. An immunohistochemical study. J. Exp. Clin. Cancer Res. 2007, 26:353-359.
173. Torp S.H., Helseth E., Dalen A., Unsgaard G. Epidermal growth factor receptor expression in human gliomas. Cancer Immunol. Immunother. 1991, 33:61-64.
174. Tsai W., Morielli A.D., Peralta E.G. The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity. Embo J. 1997, 16:4597-4605.
175. Ueki T., Fujita M., Sato K., Asai K., Yamada K., Kato T. Epidermal growth factor down-regulates connexin-43 expression in cultured rat cortical astrocytes. Neurosci. Lett. 2001, 313:53-56.
176. Volterra A., Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat. Rev. Neurosci. 2005, 6:626-640.
177. Voutilainen M.H., Back S., Porsti E., Toppinen L., Lindgren L., Lindholm P., Peranen J., Saarma M., Tuominen R.K. Mesencephalic astrocyte-derived neurotrophic factor is neurorestorative in rat model of Parkinson's disease. J. Neurosci. 2009, 29:9651-9659.
178. Wagner B., Natarajan A., Grunaug S., Kroismayr R., Wagner E.F., Sibilia M. Neuronal survival depends on EGFR signaling in cortical but not midbrain astrocytes. Embo J. 2006, 25:752-762.
179. Waha A., Baumann A., Wolf H.K., Fimmers R., Neumann J., Kindermann D., Astrahantseff K., Blumcke I., von Deimling A., Schlegel U. Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas. J. Neurosurg. 1996, 85:634-641.
180. Wang D.D., Bordey A. The astrocyte odyssey. Prog. Neurobiol. 2008, 86:342-367.
181. Werner M.H., Nanney L.B., Stoscheck C.M., King L.E. Localization of immunoreactive epidermal growth factor receptors in human nervous system. J. Histochem. Cytochem. 1988, 36:81-86.
182. White R.E., Yin F.Q., Jakeman L.B. TGF-alpha increases astrocyte invasion and promotes axonal growth into the lesion following spinal cord injury in mice. Exp. Neurol. 2008.
183. Xie G., Cheng K., Shant J., Raufman J.P. Acetylcholine-induced activation of M3 muscarinic receptors stimulates robust matrix metalloproteinase gene expression in human colon cancer cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296:G755-G763.
184. Yamada M., Ikeuchi T., Hatanaka H. The neurotrophic action and signalling of epidermal growth factor. Prog. Neurobiol. 1997, 51:19-37.
185. Yamaguchi S., Nakanishi S. Regional expression and regulation of alternative forms of mRNAs derived from two distinct transcription initiation sites of the rat mGluR5 gene. J. Neurochem. 1998, 71:60-68.
186. Ye Z.C., Wyeth M.S., Baltan-Tekkok S., Ransom B.R. Functional hemichannels in astrocytes: a novel mechanism of glutamate release. J. Neurosci. 2003, 23:3588-3596.
187. Yong V.W., Power C., Forsyth P., Edwards D.R. Metalloproteinases in biology and pathology of the nervous system. Nat. Rev. Neurosci. 2001, 2:502-511.
188. Yoshida K., Gage F.H. Fibroblast growth factors stimulate nerve growth factor synthesis and secretion by astrocytes. Brain Res. 1991, 538:118-126.
189. Yu N., Martin J.L., Stella N., Magistretti P.J. Arachidonic acid stimulates glucose uptake in cerebral cortical astrocytes. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:4042-4046.
190. Zelenaia O., Schlag B.D., Gochenauer G.E., Ganel R., Song W., Beesley J.S., Grinspan J.B., Rothstein J.D., Robinson M.B. Epidermal growth factor receptor agonists increase expression of glutamate transporter GLT-1 in astrocytes through pathways dependent on phosphatidylinositol 3-kinase and transcription factor NF-kappaB. Mol. Pharmacol. 2000, 57:667-678.
191. Zhang J.M., Wang H.K., Ye C.Q., Ge W., Chen Y., Jiang Z.L., Wu C.P., Poo M.M., Duan S. ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression. Neuron 2003, 40:971-982.
192. Zhang L., Fletcher-Turner A., Marchionni M.A., Apparsundaram S., Lundgren K.H., Yurek D.M., Seroogy K.B. Neurotrophic and neuroprotective effects of the neuregulin glial growth factor-2 on dopaminergic neurons in rat primary midbrain cultures. J. Neurochem. 2004, 91:1358-1368.
193. Zhang X., Neufeld A.H. Activation of the epidermal growth factor receptor in optic nerve astrocytes leads to early and transient induction of cyclooxygenase-2. Invest. Ophthalmol. Vis. Sci. 2005, 46:2035-2041.
194. Zhang X., Neufeld A.H. Signal transduction pathways for epidermal growth factor stimulated cyclooxygenase-2 induction in astrocytes. Exp. Eye Res. 2007, 85:280-288.
195. Zonta M., Angulo M.C., Gobbo S., Rosengarten B., Hossmann K.A., Pozzan T., Carmignoto G. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat. Neurosci. 2003, 6:43-50.
196. Zwick E., Daub H., Aoki N., Yamaguchi-Aoki Y., Tinhofer I., Maly K., Ullrich A. Critical role of calcium-dependent epidermal growth factor receptor transactivation in PC12 cell membrane depolarization and bradykinin signaling. J. Biol. Chem. 1997, 272:24767-24770.
197. Zwick E., Wallasch C., Daub H., Ullrich A. Distinct calcium-dependent pathways of epidermal growth factor receptor transactivation and PYK2 tyrosine phosphorylation in PC12 cells. J. Biol. Chem. 1999, 274:20989-20996.